Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Lymphomas

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

AN OPEN-LABEL, MULTICENTER, PHASE I/II TRIAL EVALUATING THE SAFETY, EFFICACY, AND PHARMACOKINETICS OF ESCALATING DOSES OF MOSUNETUZUMAB (BTCT4465A) AS A SINGLE AGENT AND COMBINED WITH ATEZOLIZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN’S LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA (GO29781)

  • Details

ClinicalTrials.gov ID: NCT02500407
Diagnosis Type: Lymphomas
USOR Number: 18187

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Myelomas

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A phase 1 study of SEA-BCMA in patients with relapsed or refractory multiple myeloma (SGNBCMA-001)

  • Details

ClinicalTrials.gov ID: NCT03582033
Diagnosis Type: Myelomas
USOR Number: 18126

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Solid Tumors

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Phase 1/2 First-in-Human Study of BMS-986249 Alone and in Combination with Nivolumab in Advanced Solid Tumors

  • Details

ClinicalTrials.gov ID: NCT03369223
Diagnosis Type: Solid Tumors
USOR Number: 18057

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Pancreatic Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

PANOVA-3: Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields, 150kHz) concomitant with gemcitabine and nab-paclitaxel for front-line treatment of locally-advanced pancreatic adenocarcinoma (EF-27)

  • Details

ClinicalTrials.gov ID: NCT03377491
Diagnosis Type: Pancreatic Cancer
USOR Number: 17160

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Breast Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

MammaPrint, BluePrint, and Full-genome Data Linked with Clinical Data to Evaluate New Gene EXpression Profiles: An Adaptable Registry (FLEX Registry)

  • Details

ClinicalTrials.gov ID: NCT03053193
Diagnosis Type: Breast Cancer
USOR Number: 17079

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Breast Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Corvallis

MammaPrint, BluePrint, and Full-genome Data Linked with Clinical Data to Evaluate New Gene EXpression Profiles: An Adaptable Registry (FLEX Registry)

  • Details

ClinicalTrials.gov ID: NCT03053193
Diagnosis Type: Breast Cancer
USOR Number: 17079

  • Practice Details

444 NW Elks Drive
Corvallis, OR 97330
P: (541) 754-1256

More Details View Practice Page

Lymphomas

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

(SGN35-015) A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) and CD30-expressing peripheral T-cell lymphoma (PTCL) in older patients or patients with significant comorbidities ineligible for standard chemotherapy

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Lymphomas
USOR Number: 11282

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page
1 5 6 7